Literature DB >> 25233802

Development of a material sparing bulk density test comparable to a standard USP method for use in early development of API's.

Helen Hughes1, Michael M Leane, Michael Tobyn, John F Gamble, Santiago Munoz, Pauline Musembi.   

Abstract

Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API's can be expensive and the availability of material for powder property analysis is limited. The aim of this work was to investigate a suitable small-scale, low material requirement, bulk density test which would provide comparable data to the recommended large volume USP test. Materials with a range of morphological characteristics typically seen in the pharmaceutical industry were assessed to ensure that methods were suitably robust. It was found that the USP II "low volume" test does not give equivalent results to other tests in the USP, across the range of materials. An alternative test based on the FT4 powder rheometer at a scale of 25 mL gave results equivalent to the large volume USP I standard test. The use of smaller 10-mL methods was also found to give acceptable results for materials that were considered well-behaved but were more variable with difficult to handle materials with low bulk density.

Mesh:

Substances:

Year:  2014        PMID: 25233802      PMCID: PMC4309802          DOI: 10.1208/s12249-014-0215-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant.

Authors:  Michael M Leane; Wayne Sinclair; Feng Qian; Raja Haddadin; Alan Brown; Mike Tobyn; Andrew B Dennis
Journal:  Pharm Dev Technol       Date:  2012-01-23       Impact factor: 3.133

2.  Investigation into the impact of sub-populations of agglomerates on the particle size distribution and flow properties of conventional microcrystalline cellulose grades.

Authors:  John F Gamble; Wing-Sin Chiu; Mike Tobyn
Journal:  Pharm Dev Technol       Date:  2010-06-21       Impact factor: 3.133

3.  Note on the measurement of bulk density and tapped density of powders according to the European Pharmacopeia.

Authors:  J P Sousa e Silva; D Splendor; I M B Gonçalves; P Costa; J M Sousa Lobo
Journal:  AAPS PharmSciTech       Date:  2013-07-02       Impact factor: 3.246

4.  Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development.

Authors:  Ronald G Iacocca; Christopher L Burcham; Lori R Hilden
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

5.  The effect of moisture on the flowability of pharmaceutical excipients.

Authors:  Allison Crouter; Lauren Briens
Journal:  AAPS PharmSciTech       Date:  2013-10-03       Impact factor: 3.246

  5 in total
  1 in total

1.  Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery.

Authors:  Myla Manser; Blair A Morgan; Xueya Feng; Rod G Rhem; Myrna B Dolovich; Zhou Xing; Emily D Cranston; Michael R Thompson
Journal:  Pharm Res       Date:  2022-07-19       Impact factor: 4.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.